International Cell Senescence Association

The association aims to promote research, co-operation and exchange of information among all those interested in any aspect of cellular senescence. 


Cellular senescence is a programmed state of stable cell cycle arrest that is accompanied by a complex phenotype. Senescent cells play a role in physiological processes such as tumour suppression, wound healing and embryonic development, whilst paradoxically they can contribute to ageing, cancer and age-related disease.


As such, the field of cellular senescence represents a multidisiplinary research topic.

For review articles on cell senescence click HERE


ICSA2020 #icsa2020osaka

ICSA2020 in Osaka[18575].jpg


Please save the new dates:

June 7-10, 2021

click HERE for past conferences

More senescence conferences...


15-19 Jun 2020 Roscoff (France)



Cell Senescence News


Paper of the Month

Elimination of senescent cells by β-galactosidase targeted prodrug attenuates inflammation and restores physical function in aged mice


Yusheng Cai, Huanhuan Zhou, Yinhua Zhu, Qi Sun, Yin Ji, Anqi Xue, Yuting Wang, Wenhan Chen, Xiaojie Yu, Longteng Wang, Han Chen, Cheng Li, Tuoping Luo and Hongkui Deng


Cellular senescence, a persistent state of cell cycle arrest, accumulates in aged organisms, contributes to tissue dysfunction, and drives age-related phenotypes. The clearance of senescent cells is expected to decrease chronic, low-grade inflammation and improve tissue repair capacity, thus attenuating the decline of physical function in aged organisms. However, selective and effective clearance of senescent cells of different cell types has proven challenging. Herein, we developed a prodrug strategy to design a new compound based on the increased activity of lysosomal β-galactosidase (β-gal), a primary characteristic of senescent cells. Our prodrug SSK1 is specifically activated by β-gal and eliminates mouse and human senescent cells independently of senescence inducers and cell types. In aged mice, our compound effectively cleared senescent cells in different tissues, decreased the senescence- and age-associated gene signatures, attenuated low-grade local and systemic inflammation, and restored physical function. Our results demonstrate that lysosomal β-gal can be effectively leveraged to selectively eliminate senescent cells, providing a novel strategy to develop anti-aging interventions.


To learn more about young ICSA (yICSA), click here!


About ICSA


Manuel Serrano, 

Institute for Research

and Biomedicine, Barcelona, 



Oliver Bischof

Institut Pasteur,

Paris, France


Sushma-Nagaraja Grellscheid, 

Durham University,

Durham, UK


Romuald Binet,

 Ludwig Institute for Cancer Research, Oxford, UK

Website Manager

Dominick Burton,


University, UK

Steering Committee Members

Lars Zender

University Hospital Tübingen,

Tübingen, Germany

Manuel Collado,
Health Research Institute of Santiago de Compostela,

Santiago de Compostela, Spain

Cleo Bishop
Senior Lecturer
Blizard Institute

London, UK

Clemens Schmitt

Charité-Universitätsmedizin Berlin (CVK), and Max-Delbrück-Center for Molecular Medicine, Berlin, German

Dorothy Bennett 

St George's,

University of London,


Marco Demaria

Faculty of Medical Sciences

University of Groningen,


Andrea Maier

Royal Melbourne Hospital

University of Melbourne,


Gerardo Ferbeyre 

Département de biochimie
Faculté de Médecine
Université de Montréal


Learn More

Live Longer, Live Well

Telomeres and Cell Senescence

Researchers Extend Lifespan by as Much as 35 Percent in Mice


ICSA Membership

How to join ICSA?

The cost of registration for one year of ICSA membership is:

  • Standard - 50€

  • Student/Postdoc - 25€

To become a member, follow this link.

*** REGISTER NOW FOR 2020 ***